Dimera Incorporated is a small west coast company dedicated to discovering novel medical concepts to address important medical needs (i.e., the leading cause of death and dysfunction, which is cardiovascular disease) for women and men. Visit here to learn of recent advances in research progress on cardiovascular (CV) disease--the number 1 killer.
Dimera Incorporated has developed the 1st heart drug for women. Dimera approaches the different underlying cause (microvascular ischemia) in women by systemically discovering the causes--rather than just the symptoms. This more arduous path has important virtues, allowing discovery of the molecular pathway causing the problem, while simultaneously minimizing unwanted side-effects.
The August 2009 patent of Dimera to treat symptoms of peripheral vascular disease (PVD), also known as PAD, extends the pioneering concept of gene expression modulators to improve human health.
© 1997-2009 Dimera Incorporated